P Burtin
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 0.5%
- Immunology top 5%
- Neurology top 2%
- Oncology top 10%
- Co-authors
- Reinhard HohlfeldErnst‐Wilhelm RaduePeter A. CalabresiLudwig KapposKrzysztof SelmajChris H. PolmanLixin Zhang-AubersonCatherine Agoropoulou
- Topics
- Allergic Rhinitis and Sensitization (7 papers)Dermatology and Skin Diseases (7 papers)Anesthesia and Sedative Agents (6 papers)
- Partner nations
- FranceSwitzerlandUnited Kingdom
In The Last Decade
P Burtin
35 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 1.8k
- Pathology and Forensic Medicine 1.6k
- Immunology 638
- Neurology 525
- Oncology 443
Countries citing papers authored by P Burtin
This map shows the geographic impact of P Burtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Burtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Burtin more than expected).
Fields of papers citing papers by P Burtin
This network shows the impact of papers produced by P Burtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Burtin. The network helps show where P Burtin may publish in the future.
Co-authorship network of co-authors of P Burtin
This figure shows the co-authorship network connecting the top 25 collaborators of P Burtin. A scholar is included among the top collaborators of P Burtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Burtin. P Burtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosisbreakdown → | 1960 |
| 2 | Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosisbreakdown → | 1015 |
| 3 | 37 | |
| 4 | 49 | |
| 5 | 6 | |
| 6 | 48 | |
| 7 | 90 | |
| 8 | 116 | |
| 9 | 8 | |
| 10 | 10 | |
| 11 | 2 | |
| 12 | 59 | |
| 13 | 1 | |
| 14 | 4 | |
| 15 | 113 | |
| 16 | Hypotension with midazolam and fentanyl in the newborn letter | 3 |
| 17 | 1 | |
| 18 | Maladie de Waldenström et amylose. (A propos d'une observation anatomo-clinique) | 0 |
| 19 | 4 | |
| 20 | [Immunochemical diffusion methods in a gelatinous medium]. | 1 |
About P Burtin
P Burtin is a scholar working on Immunology and Allergy, Anesthesiology and Pain Medicine and Dermatology, having authored 40 papers that have together received 4.0k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (7 papers), Dermatology and Skin Diseases (7 papers) and Anesthesia and Sedative Agents (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.6k citations), Developmental Neuroscience (161 citations) and Neurology (314 citations). P Burtin has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include Reinhard Hohlfeld, Ernst‐Wilhelm Radue, Peter A. Calabresi, Ludwig Kappos, Krzysztof Selmaj, Chris H. Polman, Lixin Zhang-Auberson, Catherine Agoropoulou, Paul O’Connor and Małgorzata Leyk. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.